litlas
ログインアカウント作成

Michel Sadelain

1990–2026 年に発表

173
論文数
59,152
被引用数
107
h 指数
169
i10 指数

被引用数

Michel Sadelain の年別被引用数1990 年: 被引用 1 件1991 年: 被引用 6 件1992 年: 被引用 3 件1993 年: 被引用 3 件1994 年: 被引用 8 件1995 年: 被引用 18 件1996 年: 被引用 24 件1997 年: 被引用 24 件1998 年: 被引用 22 件1999 年: 被引用 27 件2000 年: 被引用 42 件2001 年: 被引用 80 件2002 年: 被引用 112 件2003 年: 被引用 116 件2004 年: 被引用 156 件2005 年: 被引用 125 件2006 年: 被引用 100 件2007 年: 被引用 122 件2008 年: 被引用 116 件2009 年: 被引用 158 件2010 年: 被引用 268 件2011 年: 被引用 289 件2012 年: 被引用 308 件2013 年: 被引用 494 件2014 年: 被引用 382 件2015 年: 被引用 631 件2016 年: 被引用 732 件2017 年: 被引用 848 件2018 年: 被引用 1,085 件2019 年: 被引用 2,613 件2020 年: 被引用 3,194 件2021 年: 被引用 3,307 件2022 年: 被引用 2,669 件2023 年: 被引用 2,530 件2024 年: 被引用 3,728 件2025 年: 被引用 2,221 件2026 年: 被引用 101 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 7,473 件、この内訳の 33.3%中国: 引用元論文 3,248 件、この内訳の 14.5%ドイツ: 引用元論文 1,406 件、この内訳の 6.3%イギリス: 引用元論文 1,127 件、この内訳の 5%イタリア: 引用元論文 813 件、この内訳の 3.6%フランス: 引用元論文 734 件、この内訳の 3.3%日本: 引用元論文 569 件、この内訳の 2.5%カナダ: 引用元論文 563 件、この内訳の 2.5%スペイン: 引用元論文 509 件、この内訳の 2.3%オーストラリア: 引用元論文 500 件、この内訳の 2.2%スイス: 引用元論文 485 件、この内訳の 2.2%オランダ: 引用元論文 481 件、この内訳の 2.1%
0%33.3%その他 20.2%

機関

分野

  • Medicine59.3%
  • Biochemistry, Genetics and Molecular Biology25.7%
  • Immunology and Microbiology9.3%
  • Neuroscience2.3%
  • Engineering1.9%
  • Materials Science0.5%
  • その他1%

トピック

  • CAR-T cell therapy research16.3%
  • Virus-based gene therapy research5.6%
  • Immune Cell Function and Interaction5.6%
  • Immunotherapy and Immune Responses5.2%
  • CRISPR and Genetic Engineering4%
  • Cancer Immunotherapy and Biomarkers3.5%
  • その他59.8%

共著者

全論文

検索で開く
  1. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

    著者: Luis A. Rojas, Zachary Sethna, Kevin C. Soares, Cristina Olcese, Nan Pang, Erin Patterson, Jayon Lihm, Nicholas Ceglia, Pablo Guasp, Alexander L. Chu, Rebecca Yu, Adrienne Kaya Chandra, Theresa Waters, Jennifer Jin Ruan, Masataka Amisaki, Abderezak Zebboudj, Zagaa Odgerel, George C. Payne, Evelyna Derhovanessian, Felicitas Müller, Ina Rhee, Mahesh Yadav, Anton Dobrin, Michel Sadelain, Marta Łuksza, Noah A. Cohen, Laura H. Tang, Olca Baştürk, Mithat Gönen, Seth S. Katz, Richard Kinh Gian, Andrew S. Epstein, Parisa Momtaz, Wungki Park, Ryan Sugarman, Anna M. Varghese, Elizabeth Won, Avni M. Desai, Alice C. Wei, Michael I. D’Angelica, T. Peter Kingham, Ira Mellman, Taha Merghoub, Jedd D. Wolchok, Uğur Şahin, Özlem Türeci, Benjamin D. Greenbaum, William R. Jarnagin, Jeffrey A. Drebin, Eileen M. O’Reilly, Vinod P. Balachandran - Nature 2023 被引用: 1,350

  2. Senolytic CAR T cells reverse senescence-associated pathologies

    著者: Corina Amor, Judith Feucht, Josef Leibold, Yu-Jui Ho, Changyu Zhu, Direna Alonso‐Curbelo, Jorge Mansilla‐Soto, Jacob A. Boyer, Xiang Li, Theodoros Giavridis, Amanda Kulick, Shauna L Houlihan, Ellinor I.B. Peerschke, Scott L. Friedman, Vladimir Ponomarev, Alessandra Piersigilli, Michel Sadelain, Scott W. Lowe - Nature 2020 被引用: 1,079

  3. Chimeric Antigen Receptor Therapy

    著者: Carl H. June, Michel Sadelain - New England Journal of Medicine 2018 被引用: 2,280

  4. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy

    著者: Emma Morris, Sattva S. Neelapu, Theodoros Giavridis, Michel Sadelain - Nature reviews. Immunology 2021 被引用: 1,039

  5. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

    著者: Jae H. Park, Isabelle Rivière, Mithat Gönen, Xiuyan Wang, Brigitte Sénéchal, Kevin J. Curran, Craig S. Sauter, Yongzeng Wang, Bianca Santomasso, Elena Mead, Mikhail Roshal, P. Maslak, Marco L. Davila, Renier J. Brentjens, Michel Sadelain - New England Journal of Medicine 2018 被引用: 2,675

  6. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection

    著者: Justin Eyquem, Jorge Mansilla‐Soto, Theodoros Giavridis, Sjoukje J. C. van der Stegen, Mohamad Hamieh, Kristen Cunanan, Ashlesha Odak, Mithat Gönen, Michel Sadelain - Nature 2017 被引用: 1,854

  7. Gene therapy comes of age

    著者: Cynthia E. Dunbar, Katherine A. High, J. Keith Joung, Donald B. Kohn, Keiya Ozawa, Michel Sadelain - Science 2018 被引用: 1,378

  8. CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade

    著者: Theodoros Giavridis, Sjoukje J. C. van der Stegen, Justin Eyquem, Mohamad Hamieh, Alessandra Piersigilli, Michel Sadelain - Nature Medicine 2018 被引用: 1,262

  9. The Basic Principles of Chimeric Antigen Receptor Design

    著者: Michel Sadelain, Renier J. Brentjens, Isabelle Rivière - Cancer Discovery 2013 被引用: 1,498

  10. A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

    著者: Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière, Stephen B. Solomon, Valerie W. Rusch, Roisin E. O’Cearbhaill, Amy Zhu, Waseem Cheema, Navin K. Chintala, Elizabeth Halton, John Pineda, Rocío Pérez-Johnston, Kay See Tan, Bobby Daly, Jose A. Araujo Filho, Daniel Ngai, Erin McGee, A. Vincent, Claudia Diamonte, Jennifer L. Sauter, Shanu Modi, Devanjan Sikder, Brigitte Sénéchal, Xiuyan Wang, William D. Travis, Mithat Gönen, Charles M. Rudin, Renier J. Brentjens, David R. Jones, Michel Sadelain - Cancer Discovery 2021 被引用: 560

  11. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

    著者: Stuart M. Chambers, Christopher A. Fasano, Eirini P. Papapetrou, Mark Tomishima, Michel Sadelain, Lorenz Studer - Nature Biotechnology 2009 被引用: 3,674

  12. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

    著者: Marco L. Davila, Isabelle Rivière, Xiuyan Wang, Shirley Bartido, Jae H. Park, Kevin J. Curran, Stephen S. Chung, Jolanta Stefanski, Oriana Bórquez-Ojeda, Malgorzata Olszewska, Jinrong Qu, Teresa Wasielewska, Qing He, Mitsú J. Fink, Himaly Shinglot, Maher Youssif, Mark Satter, Yongzeng Wang, James Hosey, Hilda Quintanilla, Elizabeth Halton, Yvette Bernal, Diana Bouhassira, Maria E. Arcila, Mithat Gönen, Gail J. Roboz, P. Maslak, Dan Douer, Mark G. Frattini, Sergio Giralt, Michel Sadelain, Renier J. Brentjens - Science Translational Medicine 2014 被引用: 2,497

  13. CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

    著者: Mohamad Hamieh, Anton Dobrin, Annalisa Cabriolu, Sjoukje J. C. van der Stegen, Theodoros Giavridis, Jorge Mansilla‐Soto, Justin Eyquem, Zeguo Zhao, Benjamin M. Whitlock, Matthew M. Miele, Zhuoning Li, Kristen Cunanan, Morgan Huse, Ronald C. Hendrickson, Xiuyan Wang, Isabelle Rivière, Michel Sadelain - Nature 2019 被引用: 665

  14. Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

    著者: Bianca Santomasso, Jae H. Park, Darin Salloum, Isabelle Rivière, Jessica Flynn, Elena Mead, Elizabeth Halton, Xiuyan Wang, Brigitte Sénéchal, Terence J. Purdon, Justin R. Cross, Hui Liu, Behroze Vachha, Xi Chen, Lisa M. DeAngelis, Daniel Li, Yvette Bernal, Mithat Gönen, Hans-Guido Wendel, Michel Sadelain, Renier J. Brentjens - Cancer Discovery 2018 被引用: 924

  15. Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

    著者: Leonid Cherkassky, Aurore Morello, Jonathan Villena‐Vargas, Yang Feng, Dimiter S. Dimitrov, David R. Jones, Michel Sadelain, Prasad S. Adusumilli - Journal of Clinical Investigation 2016 被引用: 1,063

  16. Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells

    著者: Zeguo Zhao, Maud Condomines, Sjoukje J. C. van der Stegen, Fabiana Perna, Christopher C. Kloss, Gertrude Gunset, Jason Plotkin, Michel Sadelain - Cancer Cell 2015 被引用: 838

  17. CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

    著者: Renier J. Brentjens, Marco L. Davila, Isabelle Rivière, Jae H. Park, Xiuyan Wang, Lindsay G. Cowell, Shirley Bartido, Jolanta Stefanski, Clare Taylor, Malgorzata Olszewska, Oriana Bórquez-Ojeda, Jinrong Qu, Teresa Wasielewska, Qing He, Yvette Bernal, Ivelise Rijo, Cyrus V. Hedvat, Rachel Kobos, Kevin J. Curran, Peter G. Steinherz, Joseph G. Jurcic, Todd Rosenblat, P. Maslak, Mark G. Frattini, Michel Sadelain - Science Translational Medicine 2013 被引用: 2,077

  18. Therapeutic T cell engineering

    著者: Michel Sadelain, Isabelle Rivière, Stanley R. Riddell - Nature 2017 被引用: 898

  19. Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency

    著者: Judith Feucht, Jie Sun, Justin Eyquem, Yu-Jui Ho, Zeguo Zhao, Josef Leibold, Anton Dobrin, Annalisa Cabriolu, Mohamad Hamieh, Michel Sadelain - Nature Medicine 2018 被引用: 543

  20. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

    著者: Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly V. Amelsberg, Sean M. Devlin, Raymone Pajarillo, John Slingerland, Silvia Beghi, Pamela S. Herrera, Paul A. Giardina, Annelie Clurman, Emmanuel Agyemang Dwomoh, Gabriel K. Armijo, Antonio L. C. Gomes, Eric R. Littmann, Jonas Schlüter, Emily Fontana, Ying Taur, Jae H. Park, Maria Lia Palomba, Elizabeth Halton, Josel D. Ruiz, Tania Jain, Martina Pennisi, Aishat Olaide Afuye, Miguel‐Angel Perales, Craig W. Freyer, Alfred L. Garfall, Shannon Gier, Sunita D. Nasta, Daniel J. Landsburg, James N. Gerson, Jakub Svoboda, Justin R. Cross, Elise A. Chong, Sergio Giralt, Saar Gill, Isabelle Rivière, David L. Porter, Stephen J. Schuster, Michel Sadelain, Noelle V. Frey, Renier J. Brentjens, Carl H. June, Eric G. Pamer, Jonathan U. Peled, Andrea Facciabene, Marcel R.M. van den Brink, Marco Ruella - Nature Medicine 2022 被引用: 309

  21. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

    著者: John Maher, Renier J. Brentjens, Gertrude Gunset, Isabelle Rivière, Michel Sadelain - Nature Biotechnology 2002 被引用: 1,019

  22. Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction

    著者: Corina Amor, Inés Fernández-Maestre, Saria Chowdhury, Yu-Jui Ho, Sandeep Nadella, Courtenay Graham, Sebastian E. Carrasco, Emmanuella Nnuji-John, Judith Feucht, Clemens Hinterleitner, Valentin J.A. Barthet, Jacob A. Boyer, Riccardo Mezzadra, Matthew Wereski, David A. Tuveson, Ross L. Levine, Lee W. Jones, Michel Sadelain, Scott W. Lowe - Nature Aging 2024 被引用: 184

  23. The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells

    著者: Katrin Mestermann, Theodoros Giavridis, Justus Weber, Julian Rydzek, Silke Frenz, Thomas Nerreter, Andreas Mades, Michel Sadelain, Hermann Einsele, Michael Hudecek - Science Translational Medicine 2019 被引用: 503

  24. PD-1– and CTLA-4–Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses

    著者: V D Fedorov, Maria Themeli, Michel Sadelain - Science Translational Medicine 2013 被引用: 731